Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 34

Sort by

Sort Order Select

Journal Articles

Reduced Non Relapse Mortality (NRM) and Survivable Acute Graft Versus Host Disease (GVHD) in the Current Era of Myeloablative Ex Vivo T-Cell Depleted (TCD) Transplantation

Natasha A Jain, MD, Prathima Anandi, MD, Upneet Chawla, BS, MD, Sawa Ito, MD PhD, Debbie Draper, RN, Eleftheria Koklanaris, RN, Sara Hauffe, RN, Jeanine Superata, RN, Robert Q. Le, MD PhD, David Stroncek, MD, Pawel Muranski, MD, Minoo Battiwalla, MD MS, John Barrett, MD

Blood (2016) 128 (22): 4596.

https://doi.org/10.1182/blood.V128.22.4596.4596

Published: 2016

Journal Articles

Comparison of Donor KIR Genotype, Recipient CMV Reactivation and Pretransplant MRD in Predicting Relapse after Ex Vivo T-Deplete Allohsct

Robert Q. Le, MD PhD, Prathima Anandi, MD, Xin Tian, PhD, Sawa Ito, MD, Natasha A Jain, MD, Meghali Goswami, Catherine E. Lai, MD, Christopher S. Hourigan, MDPhD, Sharon Adams, Nancy F. Hensel, Austin John Barrett, MDFRCP,FRCPath, Minoo Battiwalla, MD MS

Blood (2015) 126 (23): 3212.

https://doi.org/10.1182/blood.V126.23.3212.3212

Published: 2015

Journal Articles

T Cell Depleted Allogeneic Stem Cell Transplants for Hematological Malignancies: A 20 Year Experience Shows No Relationship Between Choice of Transplanted T Cell Dose or Delayed T Cell Add-Back on Major Outcomes

Prathima Anandi, MD, Xin Tian, PhD, Puja D. Chokshi, Noelle Watters, Sawa Ito, Minoo Battiwalla, MD MS, Austin John Barrett, MDFRCP,FRCPath

Blood (2015) 126 (23): 2013.

https://doi.org/10.1182/blood.V126.23.2013.2013

Published: 2015

Journal Articles

Extensive Chronic Graft-Versus-Host-Disease Significantly Increases the Risk of Severe and Multifocal Genital Tract HPV Disease in Long-Term Survivors of Allogeneic Stem Cell Transplantation

Dana L Shanis, MD, Prathima Anandi, MD, Caitlin Grant, Priyanka A Pophali, MD, Eleftheria Koklanaris, Bipin N. Savani, MD, Austin John Barrett, MDFRCP,FRCPath, Minoo Battiwalla, MD MS, Pamela Stratton, MD

Blood (2015) 126 (23): 1956.

https://doi.org/10.1182/blood.V126.23.1956.1956

Published: 2015

Journal Articles

A Novel Standardized Quantitative Suppression Assay Reveals a Diversity of Human Immune-Regulatory Cell Potency

Samantha Miner, Nancy F. Hensel, Bahey Salem, Neil Dunavin, MD, Kazushi Tanimoto, MD, Minoo Battiwalla, MD MS, Kit Lu, MD, Keyvan Keyvanfar, BS, Marianna Sabatino, David Stroncek, Patrick J Hanley, PhD, Catherine M. Bollard, MBChB, MD, Katayoun Rezvani, MD, PhD, Marcin Kortylewski, PhD, Pawel Muranski, MD, John Barrett, MD, Sawa Ito, MD

Blood (2014) 124 (21): 316.

https://doi.org/10.1182/blood.V124.21.316.316

Published: 2014

Journal Articles

A Suppressive Microenvironment in Acute Myeloid Leukemia Induces Global Alteration of T and NK Cell Profiles - Evidence for Immune-Editing Effect By Leukemia

Sawa Ito, MD, John Barrett, MD, Bipin N. Savani, MD, Madan Jagasia, MBBS, MS, Eolia Brissot, Samantha Miner, Nancy F. Hensel, Fariba Chinian, M.S., Keyvan Keyvanfar, BS, Minoo Battiwalla, MD MS, Michael R Savona, MD, Sanjay Mohan, MD, Mattias Carlsten, MD PhD, Pawel Muranski, MD, Stephen A. Strickland, MD MSCI

Blood (2014) 124 (21): 1047.

https://doi.org/10.1182/blood.V124.21.1047.1047

Published: 2014

Journal Articles

Alemtuzumab Achieved Durable Hematologic Response In Heavily Treated T-Large Granular Lymphocytosis Irrespective To STAT3 Mutation Or V-Beta Clone Size

Bogdan Dumitriu, MD, Phillip Scheinberg, MD, Sawa Ito, Nicole Stephens, BS, Yunce Muharrem, MD, Emily King, Sachiko Kajigaya, PhD, J. Joseph Melenhorst, PhD, Fariba Chinian, M.S., Keyvan Keyvanfar, BS, Minoo Battiwalla, MD, MS, Pawel Muranski, MD, Neal S. Young, MD, A. John Barrett

Blood (2013) 122 (21): 3705.

https://doi.org/10.1182/blood.V122.21.3705.3705

Published: 2013

Journal Articles

Low CD34 Cell Dose Is Associated With Higher Non-Relapse and Overall Mortality After Reduced Intensity Conditioning Hematopoietic Cell Transplantation For Acute Myeloid Leukemia and Myelodysplastic Syndrome

Johan Thörlén, MD, Olle Ringdén, MD, PhD, Jennifer Le Rademacher, PhD, Minoo Battiwalla, MD, MS, Junfang Chen, MS, Vincent T. Ho, MD, Partow Kebriaei, MD, Carolyn A. Keever-Taylor, PhD, Tamila L. Kindwall-Keller, DO, Hillard M. Lazarus, MD, Mary J. Laughlin, MD, Michael Lill, MD, BS, Tracey A. O’Brien, FRACP, MBChB, MHL, BSc, Miguel Angel Perales, MD, Vanderson Rocha, MD, PhD, Bipin N. Savani, MD, David Szwajcer, MD, FRCPC, David Valcarcel, MD, Mary Eapen, MBBS, MS

Blood (2013) 122 (21): 3342.

https://doi.org/10.1182/blood.V122.21.3342.3342

Published: 2013

Journal Articles

Myeloid Leukemias Directly Suppress T Cell Proliferation Through STAT3 and Arginase Pathways

Samantha Miner, B.S., Sawa Ito, Kazushi Tanimoto, MD, Nancy F. Hensel, Fariba Chinian, M.S., Keyvan Keyvanfar, BS, Christopher S. Hourigan, MD, PhD, Minoo Battiwalla, MD, MS, J. Joseph Melenhorst, PhD, Pawel Muranski, MD, A. John Barrett

Blood (2013) 122 (21): 3885.

https://doi.org/10.1182/blood.V122.21.3885.3885

Published: 2013

Journal Articles

Comorbidity Measures In Ex Vivo T Cell Depleted Allogeneic Hematopoietic Stem Cell Transplantation (HCT)

Robert Quan Le, MD, PhD, Natasha A Jain, MD, Xin Tian, PhD, Sawa Ito, Kit Lu, MD, Janice Haggerty, RN, Debbie A Draper, RN, Kamna Chawla, MD, MS, A. John Barrett, MD, FRCP, Minoo Battiwalla, MD, MS

Blood (2013) 122 (21): 2124.

https://doi.org/10.1182/blood.V122.21.2124.2124

Published: 2013

Journal Articles

High Levels Of IL-27 Occur In Newly Diagnosed Acute Myeloid Leukemia (AML) and May Influence Outcome By Suppressing T Cell Function

Nicole Stephens, BS, Sawa Ito, Stephen A. Strickland, MD, MSCI, Bipin N. Savani, MD, Madan Jagasia, MBBS, MS, J. Joseph Melenhorst, PhD, Fang Yin, MD, Nancy F. Hensel, Fariba Chinian, M.S., Xingmin Feng, PhD, Leigh Samsel, MS, Keyvan Keyvanfar, BS, Christopher S. Hourigan, MD, PhD, Minoo Battiwalla, MD, MS, Pawel Muranski, MD, A. John Barrett

Blood (2013) 122 (21): 2567.

https://doi.org/10.1182/blood.V122.21.2567.2567

Published: 2013

Journal Articles

Inhaled Cyclosporine For The Treatment Of Bronchiolitis Obliterans Following Hematopoietic Stem Cell Transplantation (HSCT) Or Lung Transplantation

Nicole Gormley, MD, Catalina Ramos, RN, BSN, Robert Reger, Margaret Tropea, Xin Tian, PhD, Elena Cho, RN, MSN, Debra Reda, RN, Michael Terrin, MD, Leigh Samsel, MS, Millie Whatley, James Shelhamer, MD, Clara C. Chen, MD, Minoo Battiwalla, MD, MS, A. John Barrett, Tim Corcoran, PhD, Aldo Iacono, MD, J. Philip McCoy, PhD, Anthony Suffredini, MD, Richard W. Childs, MD

Blood (2013) 122 (21): 2057.

https://doi.org/10.1182/blood.V122.21.2057.2057

Published: 2013

Journal Articles

Contrast Enhanced Cardiac CT Detects Coronary Artery Disease In 44% Of Asymptomatic Long-Term Adult Allogeneic Stem Cell Transplant Survivors

Natasha A Jain, MD, Marcus Y Chen, MD, Sujata Shanbhag, MD, Kit Lu, MD, Priyanka A Pophali, MD, Sawa Ito, Eleftheria K Koklanaris, BSN, Christopher S. Hourigan, MD, PhD, A. John Barrett, MD, Minoo Battiwalla, MD, MS

Blood (2013) 122 (21): 2080.

https://doi.org/10.1182/blood.V122.21.2080.2080

Published: 2013

Journal Articles

Phase 1 Trial Of Bone Marrow Stromal Cells (Bone Marrow-derived MSCS) To Treat Tissue Damage In Allogeneic Stem Cell Transplant Recipients: Biological Markers Correlate With Clinical Responses and Survival

Minoo Battiwalla, MD, MS, Fang Yin, MD, Sawa Ito, Xingmin Feng, PhD, Fariba Chinian, M.S., J. Joseph Melenhorst, PhD, Eleftheria K Koklanaris, BSN, Marianna Sabatino, David Stroncek, MD, Leigh Samsel, MS, Jeffrey K. Klotz, MD, Nancy F. Hensel, Pamela Robey, PhD, A. John Barrett, MD

Blood (2013) 122 (21): 3282.

https://doi.org/10.1182/blood.V122.21.3282.3282

Published: 2013

Journal Articles

A Novel Multi-Gene Expression Array Allows Highly Sensitive Detection Of Minimal Residual Disease and Predicts Relapse Outcomes In Acute Myeloid Leukemia

Meghali Goswami, BS, Katherine S. McGowan, Kit Lu, MD, Sandhya R. Panch, MD, MPH, Nancy F. Hensel, Minoo Battiwalla, MD, MS, A. John Barrett, MD, Christopher S. Hourigan, MD, PhD

Blood (2013) 122 (21): 3318.

https://doi.org/10.1182/blood.V122.21.3318.3318

Published: 2013

Journal Articles

Transplantation For Myelodysplastic Syndrome Evolving From Aplastic Anemia Treated With Immunosuppressive Therapy: From The Fred Hutchinson Cancer Research Center and Center For International Bone Marrow Transplantation Research

Sung-Yong Kim, MD, Jennifer Le Rademacher, PhD, Jeanette Carreras, MPH, Joseph H. Antin, MD, Paolo Anderlini, MD, Mouhab Ayas, MD, Minoo Battiwalla, MD, MS, Joanne Kurtzberg, MD, Ryotaro Nakamura, MD, Mary Eapen, MBBS, MS, H. Joachim Deeg, MD

Blood (2013) 122 (21): 924.

https://doi.org/10.1182/blood.V122.21.924.924

Published: 2013

Journal Articles

Myeloid-Derived Suppressor Phenotype of Leukemic Blasts in Association with Increased Suppressor T Cell Subsets in Acute Myelogenous Leukemia– Evidence for Immunoediting.

Sawa Ito, MD, Stephen A. Strickland, MD, MSCI, Bipin N. Savani, MD, J. Joseph Melenhorst, Ph.D., Fang Yin, MD, Pawel Muranski, MD, Nancy F. Hensel, BS, Fariba Chinian, M.S., Keyvan Keyvanfar, BS, Christopher S. Hourigan, MD, PhD, Minoo Battiwalla, MD, MS, A. John Barrett, MD

Blood (2012) 120 (21): 2528.

https://doi.org/10.1182/blood.V120.21.2528.2528

Published: 2012

Journal Articles

Amino Acid Substitution At Peptide-Binding Pockets of HLA Class I Molecules Adversely Impacts Hematopoietic Cell Transplantation Outcomes

Blood (2012) 120 (21): 467.

https://doi.org/10.1182/blood.V120.21.467.467

Published: 2012

Journal Articles

Ultra-Low Dose IL-2 Safely Expands Regulatory T Cells and CD56 bright NK Cells in Healthy Volunteers: Towards Safer Stem Cell Donors?

Sawa Ito, MD, Minoo Battiwalla, MD, MS, J. Joseph Melenhorst, Ph.D., Mattias Carlsten, MD Ph.D, Angelique Biancotto, PhD, Ena Wang, M.D., Zhi Xie, Ph.D., Pawel Muranski, MD, Matthew J. Olnes, MD, PhD, Kazushi Tanimoto, MD, Paula Schum, R.N., Shira Perl, MD, Howard Dickler, MD, J. Philip McCoy, PhD, Thomas Hughes, Pharm D, Leodayan Bojanowski, DNP, CIP, RN, Nancy F. Hensel, BS, Neal S. Young, MD, A. John Barrett, MD

Blood (2012) 120 (21): 3283.

https://doi.org/10.1182/blood.V120.21.3283.3283

Published: 2012

Journal Articles

Post-Transplant Pulmonary Function Abnormalities Normalize in Survivors by the Second Decade After Allogeneic Stem Cell Transplantation

Natasha A Jain, MD, Eleftheria K. Koklanaris, BSN, Kamna Chawla, MD, MS, Priyanka A Pophali, MD, Jeffrey K. Klotz, MD, Christopher S. Hourigan, MD, PhD, Bipin N. Savani, MD, Sawa Ito, MD, A. John Barrett, MD, FRCP, Minoo Battiwalla, MD, MS

Blood (2012) 120 (21): 1967.

https://doi.org/10.1182/blood.V120.21.1967.1967

Published: 2012

NARROW

Reduced Non Relapse Mortality (NRM) and Survivable Acute Graft Versus Host Disease (GVHD) in the Current Era of Myeloablative Ex Vivo T-Cell Depleted (TCD) Transplantation

Comparison of Donor KIR Genotype, Recipient CMV Reactivation and Pretransplant MRD in Predicting Relapse after Ex Vivo T-Deplete Allohsct

T Cell Depleted Allogeneic Stem Cell Transplants for Hematological Malignancies: A 20 Year Experience Shows No Relationship Between Choice of Transplanted T Cell Dose or Delayed T Cell Add-Back on Major Outcomes

Extensive Chronic Graft-Versus-Host-Disease Significantly Increases the Risk of Severe and Multifocal Genital Tract HPV Disease in Long-Term Survivors of Allogeneic Stem Cell Transplantation

A Novel Standardized Quantitative Suppression Assay Reveals a Diversity of Human Immune-Regulatory Cell Potency

A Suppressive Microenvironment in Acute Myeloid Leukemia Induces Global Alteration of T and NK Cell Profiles - Evidence for Immune-Editing Effect By Leukemia

Alemtuzumab Achieved Durable Hematologic Response In Heavily Treated T-Large Granular Lymphocytosis Irrespective To STAT3 Mutation Or V-Beta Clone Size

Low CD34 Cell Dose Is Associated With Higher Non-Relapse and Overall Mortality After Reduced Intensity Conditioning Hematopoietic Cell Transplantation For Acute Myeloid Leukemia and Myelodysplastic Syndrome

Myeloid Leukemias Directly Suppress T Cell Proliferation Through STAT3 and Arginase Pathways

Comorbidity Measures In Ex Vivo T Cell Depleted Allogeneic Hematopoietic Stem Cell Transplantation (HCT)

High Levels Of IL-27 Occur In Newly Diagnosed Acute Myeloid Leukemia (AML) and May Influence Outcome By Suppressing T Cell Function

Inhaled Cyclosporine For The Treatment Of Bronchiolitis Obliterans Following Hematopoietic Stem Cell Transplantation (HSCT) Or Lung Transplantation

Contrast Enhanced Cardiac CT Detects Coronary Artery Disease In 44% Of Asymptomatic Long-Term Adult Allogeneic Stem Cell Transplant Survivors

Phase 1 Trial Of Bone Marrow Stromal Cells (Bone Marrow-derived MSCS) To Treat Tissue Damage In Allogeneic Stem Cell Transplant Recipients: Biological Markers Correlate With Clinical Responses and Survival

A Novel Multi-Gene Expression Array Allows Highly Sensitive Detection Of Minimal Residual Disease and Predicts Relapse Outcomes In Acute Myeloid Leukemia

Transplantation For Myelodysplastic Syndrome Evolving From Aplastic Anemia Treated With Immunosuppressive Therapy: From The Fred Hutchinson Cancer Research Center and Center For International Bone Marrow Transplantation Research

Myeloid-Derived Suppressor Phenotype of Leukemic Blasts in Association with Increased Suppressor T Cell Subsets in Acute Myelogenous Leukemia– Evidence for Immunoediting.

Amino Acid Substitution At Peptide-Binding Pockets of HLA Class I Molecules Adversely Impacts Hematopoietic Cell Transplantation Outcomes

Ultra-Low Dose IL-2 Safely Expands Regulatory T Cells and CD56 bright NK Cells in Healthy Volunteers: Towards Safer Stem Cell Donors?

Post-Transplant Pulmonary Function Abnormalities Normalize in Survivors by the Second Decade After Allogeneic Stem Cell Transplantation

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only